Related Experiment Video
Updated: May 4, 2026

08:15
Gastrointestinal Motility Monitor GIMM
Published on: December 1, 2010
34.1K
Motility changes induced by intraluminal FeSO4 in guinea pig jejunum
K Wang1, R L Bertrand, S Senadheera
1Department of Physiology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
Neurogastroenterology and Motility
|December 17, 2013
Summary
Iron supplementation can cause GI issues. Ferrous sulfate (FeSO4) affects jejunal motility and serotonin release, suggesting a pathway for reducing side effects.
Area of Science:
- Gastroenterology
- Pharmacology
- Physiology
Background:
- Dietary iron supplementation is linked to gastrointestinal (GI) side effects like nausea and diarrhea.
- High concentrations of inorganic iron may harm the intestinal lining.
- Physiological GI effects from iron supplementation concentrations are hypothesized.
Purpose of the Study:
- To investigate the impact of intraluminal ferrous sulfate (FeSO4) on jejunal motility.
- To explore the role of serotonin (5-HT) in iron's effects on the gut.
Main Methods:
- Guinea pig jejunum segments were used to record intraluminal pressure and movements.
- Peristaltic threshold was determined by the pressure evoking consecutive propulsive contractions.
- FeSO4's effect on serotonin release from tissues was measured at rest and during stimulation.
Main Results:
- FeSO4, decanoic acid, and l-phenylalanine all significantly decreased the jejunal peristaltic threshold.
- FeSO4 inhibited decanoic acid-induced segmentation, while only decanoic acid induced segmentation.
- FeSO4 increased resting serotonin (5-HT) release but reduced mechanically evoked release.
Conclusions:
- Luminal iron's effects on jejunal motility may involve altered serotonin (5-HT) release.
- Understanding the iron-enterochromaffin cell-serotonin interaction can improve iron supplementation strategies.
- Targeting this pathway could reduce common GI side effects of iron supplements.
Related Concept Videos
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
663
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
663
Gastric Motility
4.5K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
4.5K
Gastrointestinal Motility Disorders
1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.4K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.4K

